- Home
- FINS vs CYRX Comparison
FINS vs CYRX Comparison
Compare FINS & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FINS | CYRX |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 436.4M | 419.3M |
| IPO Year | 2018 | 2008 |
Fundamental Metrics
Financial Performance| Metric | FINS | CYRX |
|---|---|---|
| Price | $12.82 | $10.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.94 |
| AVG Volume (30 Days) | 45.6K | ★ 399.7K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | N/A | $8.45 |
| P/E Ratio | ★ N/A | $7.19 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.38 | $5.21 |
| 52 Week High | $13.55 | $11.45 |
Technical Indicators
Market Signals| Indicator | FINS | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 53.12 | 72.51 |
| Support Level | N/A | $9.18 |
| Resistance Level | $13.26 | $10.23 |
| Average True Range (ATR) | 0.14 | 0.41 |
| MACD | 0.04 | 0.18 |
| Stochastic Oscillator | 73.35 | 94.55 |
Price Performance
Historical ComparisonAbout FINS Angel Oak Financial Strategies Income Term Trust of Beneficial Interest
Angel Oak Financial Strats Income Term is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.